Koml signed a memorandum to acquire 90% of Can Medical

Koml signed a memorandum to acquire 90% of Can Medical

11.01.2026
7 mins read
Koml announced the signing of a memorandum of understanding to acquire a majority stake in Kan Medical. Learn more about the deal and its significance for the medical industry in Saudi Arabia.

In a strategic move aimed at strengthening its position in the Saudi market, Comel officially announced the signing of a non-binding memorandum of understanding with Kan Medical, paving the way for the acquisition of a controlling stake of between 60% and 90% in the target company. Kan Medical, a limited liability company (single-person company), specializes in the medical device manufacturing sector, a vital and rapidly growing industry in the Kingdom.

Agreement details and timeline

In a statement published on the Saudi Stock Exchange (Tadawul) website on Sunday, Comel clarified that the agreement was signed on January 8th. The memorandum of understanding is valid for 180 days and is renewable by written agreement between the two parties. During this period, the company will conduct thorough financial evaluations and due diligence, encompassing financial, legal, and technical aspects, to determine the final acquisition percentage and the fair value of the transaction before signing the final agreement and obtaining the necessary regulatory approvals.

The economic context and the importance of the healthcare sector

This deal comes at a time when the healthcare, pharmaceutical, and medical industries in Saudi Arabia are undergoing a radical transformation and remarkable development, driven by the objectives of Vision 2030. The Vision places a strong emphasis on localizing medical industries and reducing reliance on imports, making investment in local medical device manufacturing a strategic option with promising returns. Expansion in this sector is a response to the growing demand for high-quality healthcare services and medical products from both the public and private sectors.

The expected strategic impact of Comel

This potential acquisition represents a significant step forward for Comel, allowing it to diversify its investment portfolio and establish a strong presence in the medical manufacturing sector. This expansion is expected to bolster the company's business base and increase its market share, capitalizing on investment opportunities offered by the government to support local content. While the company has confirmed that the agreement will have no immediate financial impact at this time, a successful completion of the transaction will positively affect the company's financial statements in the near future and enhance its sustainable growth.

Upcoming procedures

The company indicated that it will announce any material developments regarding this transaction in due course, in accordance with the principles of transparency and disclosure applicable in the financial market. The transaction remains contingent upon the completion of due diligence and a final agreement between the parties, reflecting the company's commitment to thoroughly examining all aspects to ensure optimal value for its shareholders.

Go up